1/124
Looks like no tags are added yet.
2nd MCC of anemia
Anemia of chronic disease
What causes anemia of chronic disease?
Chronic inflammation d/t pro-inflammatory cytokines (increases with prevalence of inflammatory disorders)
**Generally MILD (rarely
Role of pro-inflammatory cytokines with anemia of chronic disease
- Inhibits erythropoietin release & Epo recetors in bone marrow
- Increased hemo-phagocytosis
- Increased hepcidin via liver — Inhibits release of iron from reticuloendothelial system
- Decreased transferrin
Lab findings of anemia of chronic disease
- Normochormic, normocytic
- Normal to high ferritin (ferritin is acute phase reactant)
- Low TIBC
- Low serum iron
- Reticulocyte inappropriately low
Iron deficiency anemia vs. anemia of chronic disease
IDA: Low MCV, low ferritin, high TIBC, low transferrin saturation, high transferrin
Chronic disease: Normal MCV, norm/high ferritin, low/normal TIBC, normal transferrin saturation, low transferrin
Goals of management of anemia of chronic disease
Treat underlying chronic disease
Indications for management of anemia of chronic disease
Affect on quality of life or functional status → Periodic transfusions OR ESAs (erythropoietin stimulating agents)
Indication & goal (values) for initiation of erythropoietin stimulating agents (ESAs)
- Hbg
What conditions are approved for ESAs?
Anemia of CKD, IBD, RA, hep C, chemo
ADRs of rapid administration of Hgb with ESA
Increased risk of VTE & CV complications; Tumor progression with certain CA
What deficiency in common in vegans & vegetarians?
B12
Causes of B12 deficiencies
- Inadequate intake
- Decreased intrinsic factor → Atrophic gastritis, gastrectomy (facilitates absorption of B12 in distal ileum)
- Pernicious anemia (AI)
What is the site of B12 absorption?
Ileum
Complications associated with elevated homocysteine levels with B12 deficiency
Increased risk of CVD
S/S & PE of B12 deficiency
- Neuropathy (demyelination of nerves) — Stocking glove paresthesias
- Loss of joint position & vibratory sense
- Irritability, depression, anxiety
- Atrophic glossitis / loss of taste
- Atrophic vaginal mucosa → Frequent vaginal / urinary infections
Lab findings with B12 deficiency
- Macrocytic (MCV >100)
- Low / low normal B12
+/- Elevated homocysteine & MMA
MCC of supplementation-resistant macrocytosis
Alcohol use disorder
What lab findings exclude B12 & folate deficiency?
Normal homocysteine & MMA
What lab should be ordered with suspicion of pernicious anemia?
Anti-parietal cell antibodies
Management of B12 deficiency
W/o neuro: PO cyanocobalamin 1,000-2,000 mcg
W/ neuro: IM cyanocobalamin (daily, then weekly, then monthly for life)
When do neurological symptoms begin to improve with B12 deficiency?
3 months
Causes of folate deficiency
- Poor intake
- Alcohol use disorder, anorexia
- Meds: Phenytoin, bactrim, sulfasalazine
Labs for folate deficiency
- Serum B12
- Serum / RBC folate
+/- MMA & homocysteiene
Management of folate deficiency
PO folic acid 1 mg
Thalassemia (define)
Hereditary disorders a/w reduced globin chain synthesis → Reduced Hgb synthesis
Lab findings of thalassemias
- Hypochromic, microcytic
- Low Hbg
- Low MCV & MCH
- Normal / elevated RBC count — Compensation for low Hgb
What is normal adult hemoglobin?
Hgb A — Alpha2-beta2 (2 alpha & 2 beta chains)
What is fetal hemoglobin & when does it switch to adult?
Hgb F — Alpha2-gamma2; Switches at 6 months
MC demographic associated with alpha thalassemia
Asian descent
Cause of alpha thalassemia
Inherited gene deletions → Reduced / absent synthesis of α-globin chains (dominance of non-alpha chains)
**More gene deletions → Increased severity (1-4)
Step-wise genotypes of alpha thalassemia
Silent carrier (1 mutation) → α-thalassemia minor/trait (2 mutations) → Hgb H disease (3 mutations) → α-thalassemia major / Hb Bart's / Hydrops fetalis (4 mutations)
**4 mutations NOT compatible w/ life
At what severity of alpha thalassemia do MCV changes occur?
α-thalassemia minor/trait (2 mutations)
Lab findings of alpha thalassemia minor/trait (2 mutations)
- Mild anemia
- Very low MCV with normal / increased RBC
- Normal / increased reticulocytes
- Genetic testing → α-globin deletion (chromosome 16)
Lab findings of alpha thalassemia Hgb H disease (3 mutations)
- Marked anemia
- Very low MCV with normal / increased RBC
- Elevated reticulocyte count
- Hypochromia, microcytosis, target cells, poikilocytosis
- Hgb electrophoresis → Hgb H
What occurs with hemoglobin H disease?
Excess beta chains for beta-4 tetramer (Hgb H) → Hemolysis
Alpha thalassemia minor/trait vs. Hgb H disease
Minor/trait: Mild anemia, normal / increased reticulocytes; 2 deletions
Hbg H: Marked anemia, elevated reticulocytes; 3 deletions (more severe)
**Both have very low MCV with normal / increased RBC
MC demographic associated with beta thalassemia
Mediterranean decent
Causes of beta thalassemia
β0 mutations → Absent β-globin synthesis
β+ mutations → Reduced β-globin synthesis
What occurs with beta thalassemia?
Excess alpha chains → α-chain tetramer formation
Beta-thalassemia major AKA (& what)
Cooley anemia — β0β0-globin gene defect → Inability to major HbgA so Hbg F remains
Presentation of beta-thalassemia major
Severe hemolytic anemia after 6 months of age
Lab findings of beta-thalassemia major
- Very low Hct
Complications associated with beta-thalassemia major
- Stunted growth
- Bone deformities & pathological fractures — High hemolysis in bone marrow → Expansion
- Hepatosplenomegaly
- Pigmented gallstones/cirrhosis/jaundice
- Frequent transfusions → Iron overload → Hemochromatosis-like (cardiac & organ damage)
Beta-thalassemia intermedia
β+β+ — Chronic hemolytic anemia → Hepatosplenomegaly & bone deformities
Lab findings of beta-thalassemia intermedia
- Peripheral smear like minor + target cells
- Modest anemia
- Hbg electrophoresis compared to major: Increased Hbg A & lower levels of Hgb F
Beta-thalassemia minor
β/β0 or β/β+ — Clinically insignificant microcytic anemia
Lab findings of beta-thalassemia minor
- Mild anemia
- Hypochromia, basophilic stippling
- Hbg electrophoresis → Hgb A 80-95% +/- very slightly elevated Hbg F
Management of mild thalassemia (α-trait / β-minor )
N/A; But important to diagnose
Management of thalassemia intermedia
N/A unless fall in Hbg
Management of thalassemia major (Hgb H / β-major )
- Regular transfusions >8/year — Maintain Hbg AND suppress endogenous erythropoiesis to prevent BM expansion
- Iron chelation — Avoid iron overload
- Folic acid supplementation
- If hypersplenism is increased transfusion requirements → Splenectomy
Management of thalassemia requiring splenectomy
- Pneumococcal polyvant 1 month prior to splenectomy
- Daily PCN for 2 years after splenectomy
Indications for transfusions with beta-thalassemia intermedia
Stress / aplastic crisis
Sickle cell anemia
- Autosomal recessive hemoglobinopathy with point mutation of glutamate → valine at β-chain making major Hb Hgb S
- Characterized by chronic hemolytic anemia & painful crises
**Difference between disease & trait
Demographic associated with sickle cell anemia / disease
African American
When does clinically significant disease occur with sickle cell?
- Homozygous for Hb S genes
- Heterozygous + other hemoglobinopathy
Effects of Hgb S & sickled cells
- 1st year of life → Decreased Hgb F & Hgb S dominates
- Chronic hemolytic anemia → Jaundice, pigmented gallstones, splenomegaly
Pathophysiology of sickle cell disease
- Unstable Hgb S polymerizes
- Sickled cells prone to hemolysis & convert to adenosine → Induces more sickling
- Clump → Vaso-occlusive crisis & ischemic injuries
Risk factors that increase polymerization of Hgb & cause sickle cell crisis
Hypoxemia, dehydration, infection, acidosis
Common S/S & PE of sickle cell disease
- Hours / days of bone pain → Spine, long bones, thoracic
- Abdominal pain, priapism
- CNS → Sagittal sinus thrombosis, stroke
- Acute chest syndrome → Chest pain, hypoxemia, bilateral pulmonary infiltrates
- Hand & foot syndrome in kids (painful swelling)
- Aplastic crises
Peak age for thrombotic stroke with sickle cell disease
6-7 years
What cases aplastic crises with sickle cell disease? Complications?
Parvovirus B19 (viruses) → Life-threatening bone marrow failure
S/S & PE of chronic sickle cell disease
- Vascular occlusion episodes → Organ damage (especially spleen d/t chronic sequestration)
- Ischemic necrosis of bone (osteomyelitis) d/t salmonella & staph
- Increased infection risk — Functional hypOsplenism, altered complement pathway
- Life expectancy 40-50 years
Diagnostic workup & findings of sickle cell anemia
- Hgb electrophoresis
- Peripheral smear → Sickled RBCs, nucleated RBCs, Howell-Jolly bodies & target cells
- Elevated indirect bilirubin levels
- Reticulocytosis, leukocytosis, thrombocytosis
- Many transfusions → High ferritin
- Hemolysis → High LDH
What is a lab finding associated with functional hyposplenism?
Howell-Jolly bodies & target cells
Hgb electrophoresis findings for sickle cell trait vs. disease
Trait: 30-45% HbS, MINIMAL HbF
Disease: NO HbA1, 80-100% HbS, some HbF
Supportive management of sickle cell anemia
- Sickle cell specialty center
- Prevention of crises — Avoid triggers, hydration, avoid substance use & high altitude
Which are vaccinations extremely important with sickle cell anemia?
NO healthy spleen to filter encapsulated organisms → Immunocompromised / functionally asplenic → HIGH RISK of infection (s. pneumo, h. flu, meningitidis, salmonella)
Vaccine requirements with sickle cell anemia
- Flu & COVID
- Conjugated pneumococcal — Requires boosters throughout adulthood
- Meningococcal — Hib-MenCY as infant + boosters
Management of acute sickle cell anemia
- Amox / PCN — High index of suspicion for gram + infection
- Aggressive hydration
- Mild pain → Ibuprofen
- Mod / severe pain → Scheduled opioids
**If acute chest syndrome present → Aggressive treatment bc deteriorates quickly
Indications for exchange transfusions for acute sickle cell anemia
Severe VOC, intractable pain, severe acute chest syndrome, stroke
Management of chronic sickle cell anemia
Hydroxyurea (cytotoxic agent) — Mainstay!
**Increased Hgb F, improves survival, decreases complications, hospitalizations, improved cerebral O2 saturation
Definitive management of sickle cell anemia
- Allogenic hematopoietic stem cell transplants (prior to end-organ damage)
- Gene therapy for age >12
Sickle cell trait
Heterozygous genotype (AS) — Hematologically normal
**NO increased mortality
Those with sickle cell trait are at increased risk of...
- Rhabdo d/t vigorous exercise
- VTE
- CKD d/t RBC in renal medulla (acidic environment)
Glucose-6-phosphate dehydrogenase deficiency
Hereditary, X-linked enzyme defect of G6PD enzyme → Depletion of NADPH & glutathione → Decreased ability to fight oxidative stress (RBC impacted the most)
MC demographic associated with G6PD deficiency
AA men
Pathophysiological findings with G6PD deficiency
- Denatured Hgb → Heinz bodies
During episodes:
- Extravascular hemolysis — Premature removal from circulation by spleen
- Splenic macrophages → Bite cells
- & intravascular hemoylsis
History finding associated with G6PD deficiency
Neonatal jaundice
Triggers that increase oxidative stress with G6PD deficiency
- Infection, fava beans
- Meds: FQs, bactrim, nitrofurantoin
Presentation of G6PD deficiency in adults
Self-limiting acute hemolytic anemia 24-72 hours post-trigger
Diagnostic workup & findings of G6PD deficiency
- Hemolytic anemia → Increased reticulocytes
- Heinz bodies, bite cells
- Hemolytic event → Schistocytes
- Definitive → Genetic testing
Nonspecific signs of hemolysis:
- Increased indirect bilirubin
- Decreased haptoglobin
- Increased LDH
Management of G6PD deficiency
Avoid triggers
AI hemolytic anemia
Rapid-onset acute anemia with premature / accelerated destruction of RBC by anti-RBC autoantibodies (IgG)
**Can be life-threatening
Pathophysiology of AI hemolytic anemia
Splenic macrophages remove RBC membrane → Spherocyte that is destroyed by spleen / liver
Causes of AI hemolytic anemia
- Idiopathic
- Rheumatological / Lupus
- Chronic lymphocytic leukemia & lymphomas
MCC of drug-induced hemolytic anemia
PCN, cefotetan, ceftriaxone
**Autoantibody vs. RBC membrane-drug complex
MC age of onset of AI hemolytic anemia
40-60 years
MC presentation of AI hemolytic anemia
Warm agglutinin hemolytic anemia — IgG autoantibody binds to RBC membrane most avidly at body temperature
Diagnostic workup & findings of AI hemolytic anemia
- Reticuloctosis
- Spherocytes +/- nucleated RBC (released by BM w/ stress)
- Hemolysis pattern → Increased indirect bili, low haptoglobin, elevated LDH
- Definitive → Direct OR indirect Coombs test
Direct vs. indirect Coombs test
Direct: Detects antibody on RBC surface
Indirect: Detects free antibody in serum
Cold agglutinin disease
- Type of AI hemolytic anemia with autoantibodies binding to RBC surface at cold temperatures
- Complement-mediated with IgM antibodies
Demographic & presentation associated with cold agglutinin disease
Acute → Age 10-30 following acute illness (myco pneumonia, EBV, CMV, measles, mumps)
Chronic → Age >50 associated with B-lymphocyte neoplasms (CLL, lymphoma)
S/S & PE of cold agglutinin disease
- Cold-induced acrocyanosis
- Anemia S/S at cold temperatures
Diagnostic workup & findings of cold agglutinin disease
- During S/S → Mild anemia, reticulocytosis, indirect hypERbili, low hapto
- Cold agglutination test → Agglutination at room temp
- Monoclonal IgM on serum protein electrophoresis / serum immunoelectrophoresis
- Low complement levels
Management of all AI hemolytic anemias
Supplementation of folate, B12 +/- Ca / vit D if LT steroids
Management of warm vs. cold AI hemolytic anemia
Warm: Prednisone (1st-line)
Cold: Rituximab (predinsone & splenectomy ineffective); Severe → Cytotoxic meds
Difficulties with management of warm & cold AI hemolytic anemia
Difficult to find compatible blood for transfusion d/t antibodies
Aplastic anemia
Bone marrow failure d/t suppression OR injury to hematopoietic stem cells → Pancytopenia
Causes of aplastic anemia
- Chemo, radiation, toxins
- Viruses: HIV, EBV, post-viral hepatitis, parvo B19, CMV
- AI suppression of T-cell medicated mechanism
When should primary bone marrow disorders OR malignancies be considered?
Aplastic anemia with bone bone, LAD, hepatosplenomegaly